Identification of an epigenetic biomarker predicting the response to therapy with APG101 in glioblastoma
© The Author 2016. Published by Oxford University Press on behalf of the European Society for Medical Oncology. All rights reserved. For permissions, please email: journals.permissionsoup.com.Background: APG101, a fully human fusion protein consisting of the extracellular domain of CD95 and the Fc-d...
Gespeichert in:
| Hauptverfasser: | , , |
|---|---|
| Dokumenttyp: | Article (Journal) |
| Sprache: | Englisch |
| Veröffentlicht: |
11 October 2016
|
| In: |
Annals of oncology
Year: 2016, Jahrgang: 27 |
| ISSN: | 1569-8041 |
| DOI: | 10.1093/annonc/mdw363.81 |
| Online-Zugang: | Verlag, kostenfrei, Volltext: http://dx.doi.org/10.1093/annonc/mdw363.81 Verlag, kostenfrei, Volltext: https://academic.oup.com/annonc/article/27/suppl_6/133P/2798859 
|
| Verfasserangaben: | M. Thiemann, C. Gieffers, C. Kunz, J. Sykora, C. Merz, H. Fricke, B. Wiestler, W. Wick |
MARC
| LEADER | 00000caa a2200000 c 4500 | ||
|---|---|---|---|
| 001 | 1565363922 | ||
| 003 | DE-627 | ||
| 005 | 20220814022530.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 171115s2016 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.1093/annonc/mdw363.81 |2 doi | |
| 035 | |a (DE-627)1565363922 | ||
| 035 | |a (DE-576)495363928 | ||
| 035 | |a (DE-599)BSZ495363928 | ||
| 035 | |a (OCoLC)1340981957 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rda | ||
| 041 | |a eng | ||
| 084 | |a 33 |2 sdnb | ||
| 100 | 1 | |a Thiemann, Markus |e VerfasserIn |0 (DE-588)136753108 |0 (DE-627)585878951 |0 (DE-576)301255229 |4 aut | |
| 245 | 1 | 0 | |a Identification of an epigenetic biomarker predicting the response to therapy with APG101 in glioblastoma |c M. Thiemann, C. Gieffers, C. Kunz, J. Sykora, C. Merz, H. Fricke, B. Wiestler, W. Wick |
| 264 | 1 | |c 11 October 2016 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a Computermedien |b c |2 rdamedia | ||
| 338 | |a Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Gesehen am 15.11.2017 | ||
| 520 | |a © The Author 2016. Published by Oxford University Press on behalf of the European Society for Medical Oncology. All rights reserved. For permissions, please email: journals.permissionsoup.com.Background: APG101, a fully human fusion protein consisting of the extracellular domain of CD95 and the Fc-domain of an IgG, has been developed by Apogenix. It was confirmed as a potent inhibitor of CD95L induced invasion of glioblastoma cells in vitro. In a randomized phase 2 study in glioblastoma patients with 1st or 2nd relapse the combined therapy of APG101 plus radiotherapy (RT) was found to be superior to RT alone in a clinically relevant order of magnitude in all efficacy endpoints (i.e. PFS-6, PFS and OS). At the same time APG101 exhibited an excellent safety profile and was well tolerated. The presented data summarizes the identification of a predictive biomarker.Methods: To identify potential biomarkers we used available tissue sections originating... | ||
| 700 | 1 | |a Wiestler, Benedikt |d 1983- |e VerfasserIn |0 (DE-588)1014415837 |0 (DE-627)705225879 |0 (DE-576)348205139 |4 aut | |
| 700 | 1 | |a Wick, Wolfgang |d 1970- |e VerfasserIn |0 (DE-588)120297736 |0 (DE-627)080586929 |0 (DE-576)186221320 |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t Annals of oncology |d Amsterdam [u.a.] : Elsevier, 1990 |g 27(2016,Supplement 6) Artikel-Nummer 133P, 1 Seite |h Online-Ressource |w (DE-627)320428796 |w (DE-600)2003498-2 |w (DE-576)098134345 |x 1569-8041 |7 nnas |a Identification of an epigenetic biomarker predicting the response to therapy with APG101 in glioblastoma |
| 773 | 1 | 8 | |g volume:27 |g year:2016 |g supplement:Supplement 6 |a Identification of an epigenetic biomarker predicting the response to therapy with APG101 in glioblastoma |
| 856 | 4 | 0 | |u http://dx.doi.org/10.1093/annonc/mdw363.81 |x Verlag |x Resolving-System |z kostenfrei |3 Volltext |
| 856 | 4 | 0 | |u https://academic.oup.com/annonc/article/27/suppl_6/133P/2798859 |x Verlag |z kostenfrei |3 Volltext |
| 951 | |a AR | ||
| 992 | |a 20171115 | ||
| 993 | |a Article | ||
| 994 | |a 2016 | ||
| 998 | |g 1014415837 |a Wiestler, Benedikt |m 1014415837:Wiestler, Benedikt |p 7 | ||
| 998 | |g 120297736 |a Wick, Wolfgang |m 120297736:Wick, Wolfgang |d 910000 |d 911100 |e 910000PW120297736 |e 911100PW120297736 |k 0/910000/ |k 1/910000/911100/ |p 8 |y j | ||
| 999 | |a KXP-PPN1565363922 |e 2987224680 | ||
| BIB | |a Y | ||
| SER | |a journal | ||
| JSO | |a {"recId":"1565363922","person":[{"family":"Thiemann","role":"aut","given":"Markus","display":"Thiemann, Markus"},{"family":"Wiestler","role":"aut","given":"Benedikt","display":"Wiestler, Benedikt"},{"family":"Wick","role":"aut","given":"Wolfgang","display":"Wick, Wolfgang"}],"relHost":[{"physDesc":[{"extent":"Online-Ressource"}],"recId":"320428796","disp":"Identification of an epigenetic biomarker predicting the response to therapy with APG101 in glioblastomaAnnals of oncology","origin":[{"publisher":"Elsevier ; Kluwer ; Oxford Univ. Press","dateIssuedKey":"1990","publisherPlace":"Amsterdam [u.a.] ; Dordrecht [u.a.] ; Oxford","dateIssuedDisp":"1990-"}],"note":["Gesehen am 12.11.20","Ungezählte Beil.: Supplement"],"type":{"bibl":"periodical","media":"Online-Ressource"},"language":["eng"],"title":[{"title":"Annals of oncology","title_sort":"Annals of oncology","subtitle":"official journal of the European Society for Medical Oncology"}],"corporate":[{"role":"isb","display":"European Society for Medical Oncology"}],"pubHistory":["1.1990 -"],"part":{"year":"2016","volume":"27","text":"27(2016,Supplement 6) Artikel-Nummer 133P, 1 Seite"},"id":{"issn":["1569-8041"],"eki":["320428796"],"zdb":["2003498-2"]}}],"name":{"displayForm":["M. Thiemann, C. Gieffers, C. Kunz, J. Sykora, C. Merz, H. Fricke, B. Wiestler, W. Wick"]},"origin":[{"dateIssuedKey":"2016","dateIssuedDisp":"11 October 2016"}],"note":["Gesehen am 15.11.2017"],"type":{"bibl":"article-journal","media":"Online-Ressource"},"language":["eng"],"title":[{"title":"Identification of an epigenetic biomarker predicting the response to therapy with APG101 in glioblastoma","title_sort":"Identification of an epigenetic biomarker predicting the response to therapy with APG101 in glioblastoma"}],"id":{"eki":["1565363922"],"doi":["10.1093/annonc/mdw363.81"]}} | ||
| SRT | |a THIEMANNMAIDENTIFICA1120 | ||